Engineered fibroblast growth factor 1 variants uncouple glucose-lowering effects from mitogenic activity with therapeutic potential for type 2 diabetes
Aleksandra Czyrek(Masaryk University), Małgorzata Zakrzewska(University of Wrocław)
Cited by 0
Related Papers
Design of fully active FGF-1 variants with increased stability
|Protein Engineering Design and Selection|2004|64
Translocation of Exogenous FGF1 and FGF2 Protects the Cell against Apoptosis Independently of Receptor Activation
|Journal of Molecular Biology|2018|34
FGF12 is a novel component of the nucleolar NOLC1/TCOF1 ribosome biogenesis complex
|Cell Communication and Signaling|2022|28
<scp>FGF</scp> homologous factors are secreted from cells to induce <scp>FGFR</scp> ‐mediated anti‐apoptotic response
|The FASEB Journal|2023|23
Uncovering key steps in FGF12 cellular release reveals a common mechanism for unconventional FGF protein secretion
|Cellular and Molecular Life Sciences|2024|7